Your session is about to expire
← Back to Search
LIFUP Neuromodulation for Healthy Controls
Study Summary
This trial will study the effect of LIFUP on emotion processing, and whether it is safe to use on healthy volunteers.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Other reimbursement is provided
Other forms of reimbursement are provided for this trial.
Who is running the clinical trial?
Media Library
- You cannot be claustrophobic.You cannot have any metal objects in your body that may be affected by an MRI scan.You need to be right-handed.You cannot be a smoker.
- Screening: It may take up to 1 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 2 null
- Follow Ups: You may be asked to continue sharing information regarding the trial for 0 Months after you stop receiving the treatment.
- Group 1: LIFUP sonication to the amygdala
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
Does this trial open the door to individuals aged 55 or higher?
"The age range for eligibile participants is 18 to 75, though there are 106 trials open exclusively to people under the legal voting age and 590 studies that accept patients above retirement."
For whom would this research be the most beneficial?
"To be selected for this clinical research, participants must have a diagnosis of psychosis and involutional depression. Those aged between 18 to 75 are eligible to apply with 24 total spots available in the study."
Are there any open enrollment opportunities for this research endeavor?
"Unfortunately, per the information on clinicaltrials.gov this trial has stopped recruiting participants. It was initially posted on January 24th 2022 and final updates were completed by 1/3/2022. Even though enrollment for this study is now closed, there are 820 other trials that currently need patient volunteers to participate in their research."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
How responsive is this trial?
Average response time
- < 2 Days
Typically responds via
Most responsive sites:
- The University of Texas Health Science Center at Houston: < 48 hours
Share this study with friends
Copy Link
Messenger